A detailed history of Citigroup Inc transactions in Schrodinger, Inc. stock. As of the latest transaction made, Citigroup Inc holds 88,264 shares of SDGR stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,264
Previous 81,261 8.62%
Holding current value
$2.18 Million
Previous $1.57 Million 4.2%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.05 - $24.02 $126,404 - $168,212
7,003 Added 8.62%
88,264 $1.64 Million
Q2 2024

Aug 12, 2024

BUY
$18.65 - $28.5 $558,716 - $853,803
29,958 Added 58.39%
81,261 $1.57 Million
Q1 2024

May 10, 2024

BUY
$24.74 - $35.13 $321,224 - $456,127
12,984 Added 33.88%
51,303 $1.39 Million
Q4 2023

Feb 09, 2024

BUY
$21.62 - $37.21 $10,399 - $17,898
481 Added 1.27%
38,319 $1.37 Million
Q3 2023

Nov 09, 2023

SELL
$27.34 - $55.37 $185,693 - $376,073
-6,792 Reduced 15.22%
37,838 $1.07 Million
Q2 2023

Aug 10, 2023

BUY
$26.1 - $49.92 $872,601 - $1.67 Million
33,433 Added 298.59%
44,630 $2.23 Million
Q1 2023

May 11, 2023

SELL
$18.09 - $27.61 $275,546 - $420,555
-15,232 Reduced 57.63%
11,197 $294,000
Q4 2022

Feb 09, 2023

BUY
$16.24 - $26.38 $32,593 - $52,944
2,007 Added 8.22%
26,429 $493,000
Q3 2022

Nov 10, 2022

BUY
$23.95 - $34.71 $369,261 - $535,158
15,418 Added 171.24%
24,422 $610,000
Q2 2022

Aug 10, 2022

BUY
$21.39 - $35.9 $113,773 - $190,952
5,319 Added 144.34%
9,004 $237,000
Q1 2022

May 12, 2022

SELL
$24.84 - $36.12 $297,781 - $433,006
-11,988 Reduced 76.49%
3,685 $125,000
Q4 2021

Feb 10, 2022

BUY
$33.38 - $59.25 $168,535 - $299,153
5,049 Added 47.52%
15,673 $546,000
Q3 2021

Nov 10, 2021

BUY
$53.75 - $76.55 $571,040 - $813,267
10,624 New
10,624 $581,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.53B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.